Clinical Trials Directory

Trials / Sponsors / Shouyao Holdings (Beijing) Co. LTD

Shouyao Holdings (Beijing) Co. LTD

Academic / Other · 15 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase I Study of SY-9453 in Patients With Advanced Solid Tumors
Advanced or Metastatic Solid Tumors With Homozygous MTAP Deletion
Phase 12026-02-01
Not Yet RecruitingStudy of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation
Advanced Solid Tumor
Phase 1 / Phase 22025-06-01
RecruitingA Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors
Advanced Solid Tumor
Phase 12024-05-30
Not Yet RecruitingA Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Non-small Cell Lung Cancer
Phase 32024-05-01
UnknownA Study to Evaluate the Mass Balance of [14C] SY-5007 in Healthy Adult Male Subjects in China
Healthy Subjects
Phase 12024-05-01
UnknownA Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SY-5007 in Healthy Su
Healthy Subjects
Phase 12024-04-01
UnknownA Study to Evaluate the Food Effects on Pharmacokinetics of SY-5007 Tablets in Healthy Subjects
Health Subjects
Phase 12024-04-01
UnknownA Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation
Advanced Solid Tumor
Phase 12023-08-10
UnknownPhase II Study of SY-3505 in Patients With ALK-positive NSCLC Who Have Failed Prior Second-Generation ALK TKI
Non-small-cell Lung Carcinoma
Phase 22023-06-30
RecruitingPhase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positi
Non-Small Cell Lung Cancer
Phase 32023-06-20
UnknownSafety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Phase 1 / Phase 22022-08-11
UnknownA Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Phase 12021-06-28
UnknownPhase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor
Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Solid Tumor
Phase 1 / Phase 22021-04-23
UnknownA First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor
Advanced Solid Tumor
Phase 12021-04-15
UnknownPhase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 1 / Phase 22020-04-26